The FDA is about to switch Nasalcrom (cromolyn) to OTC

November 1996

The FDA is about to switch Nasalcrom (cromolyn) to OTC.

It'll be marketed by McNeil Consumer Products...in the same strength as the prescription product.

Suggest trying Nasalcrom for allergic rhinitis. It reduces nasal symptoms...without the side effects that come from using antihistamines or decongestants.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

More prescriptions will be transmitted electronically
new asthma drug, Accolate (zafirlukast)
The FDA is about to switch Nasalcrom (cromolyn) to OTC
Neurology & Pain Neurontin (gabapentin) for pain
Substance Use Disorder DEA would control sales of OTC pseudoephedrine (Sudafed, etc)
Substance Use Disorder cases of clonidine abuse
STIs emerging resistance of gonorrhea to quinolone antibiotics
Infectious Diseases higher-strength form of Retrovir (zidovudine, AZT)
Infectious Diseases Valtrex (valacyclovir) for treating INITIAL episodes of genital herpes
Infectious Diseases more patients getting prednisone for shingles
Cardiology alternatives to warfarin to prevent ischemic stroke in patients with atrial fibrillation (AF)
Cardiology stop using nifedipine capsules to lower extremely high blood pressure
Renal & Urology Elmiron, the first oral therapy for interstitial cystitis
Vaccines more emphasis on COMBINING pediatric vaccines
Vaccines COMBINE Connaught's ActHIB with Tripedia (DTaP) so they can be given together in one injection
Antipsychotics You're going to hear LOTS about Zyprexa (olanzapine)

The FDA is about to switch Nasalcrom (cromolyn) to OTC

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents